Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Study of Docetaxel Versus Docetaxel Plus Genasense™ (G3139; Bcl-2 Antisense Oligonucleotide) in Patients With Previously Treated Non-Small Cell Lung Cancer

NCT00030641 is registered in ClinicalTrials.gov with Genta Incorporated as lead sponsor.

NCT NCT00030641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00030641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Study of Docetaxel Versus Docetaxel Plus Genasense™ (G3139; Bcl-2 Antisense Oligonucleotide) in Patients With Previously Treated Non-Small Cell Lung Cancer
Lead sponsor
Genta Incorporated
Phase
Phase 2/3
Overall status
Unknown status
Start date
October 31, 2001
Completion date
Not reported
Enrollment
Not reported
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer